Genmab to collaborate with Californian biotech company on three drugs
Genmab now partly owns Bolt Therapeutics after investing USD 15m in the US biotech company to develop new drugs.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Genmab and US Bolt Therapeutics have entered into a collaboration which could potentially yield three novel drug candidates.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
